GlobeNewswire Inc.T3·23mo ago
EKG First Trust Nasdaq Lux Digital Health Solutions ETF
ETF 23.42 DelayedETF quote, holdings, sector allocation, technicals, and options analytics. Expected move IV rank history Fibonacci levels
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
EKG
$23.42
—
Key stats
$23.42
- 52-Week Range
- $15.71 – $24.53
- YTD
- +23.46%
- IV Rank (30D)
- 61.24
- Straddle Price
- $2.40
- Open
- $23.14
- Day Range
- $23.14 – $23.42
- Volume
- 2,308
- Prev Close
- $22.84
About
First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) ETF
No description available.
- Exchange
- XNAS
- Inception
- 2022-03-22
- Has Options
- Yes
Fund profile
holdings as of Jun 30, 2026SEC filingthrough Jun 2026flows, SEC filings
- Expense ratio
- 0.65% prospectus, filed Jan 28, 2026
- Assets
- $4.7M shares × price, Oct 9, 2026
- Trailing yield
- —
- Average daily volume
- $214K 30 sessions
- Holdings
- 39 top 10 are 58.2%
- Listed
- Mar 22, 2022 Nasdaq
Cost32
Liquidity11
Scale0
Diversification50
Moves with. US large-cap stocks (24% of its variance, beta 0.93); Small caps over large (8% of its variance, beta 0.56). These factors explain 33% of its daily moves over the last year, so most of what drives this fund is something else.
Stated objective. The First Trust Nasdaq Lux Digital Health Solutions ETF (the Fund ) seeks investment results that correspond generally to the price and yield (before the Funds fees and expenses) of an equity index called the Nasdaq Lux Health Tech TM Index (the Index ). (from the fund's prospectus)
All 39 holdingsFlow historySimilar fundsOverlap toolAll Biotech & Health Innovation ETFs
Fund flows
through Jun 2026SEC filings- Jun 2026
- $0 latest reported month
- Latest 3 months
- $0 0.0% of assets
- Latest 12 months
- −$870K −30.9% of assets
View as a table
| Month | Net flow |
|---|---|
| Jun 2026 | $0 |
| May 2026 | $0 |
| Apr 2026 | $0 |
| Mar 2026 | $0 |
| Feb 2026 | $0 |
| Jan 2026 | $0 |
| Dec 2025 | $0 |
| Nov 2025 | $0 |
| Oct 2025 | $0 |
| Sep 2025 | $0 |
| Aug 2025 | −$870K |
| Jul 2025 | $0 |
Net creations and redemptions from the fund's SEC filings, which become public about 60 days after each quarter. Every month since 54 months ago
Similar funds
| Fund | Overlap | Fee | Assets | 1Y | |
|---|---|---|---|---|---|
| HEALGlobal X Funds Global X HealthTech ETF | 51% | 0.50% | $31M | −11.5% | compare |
| LGHTLangar Global HealthTech ETF | 39% | 0.85% | $2.5M | +5.5% | compare |
| ARKGARK Genomic Revolution ETF | 26% | 0.75% | $2.1B | +59.7% | compare |
| HTECROBO Global Healthcare Technology and Innovation ETF | 22% | 0.68% | $74M | +33.4% | compare |
| GNOMGlobal X Genomics & Biotechnology ETF | 22% | 0.50% | $101M | +63.4% | compare |
Ranked by how much of the two portfolios is the same securities.
Look-through: what the holdings say
weights as of Jun 30, 2026SEC filing- Holdings vs fair value
- −1.6% 25% under, 43% over · 96% covered
- Price / earnings
- 102.8 32% loss-making · 96% covered
- Price / book · sales
- 5.5 · 3.4 revenue growth +11.9%
- Above 200-day average
- 77% 70% above 50-day · by weight
- Short interest
- 8.6% of float, weighted · 4.2 days to cover
- Insider buying
- 6% of weight had net insider buying, 90 days; 81% net selling
- 13F holders
- +3.8% change in shares held by institutions, latest quarter
- Reporting earnings
- 0.0% of weight in 7 days; 6.1% in 14
Holdings reporting in the next 14 days
Each figure is the fund's holdings weighted by position size, using our data on those stocks, and covers only the share of the stock holdings stated. Positive fair value means the holdings trade below our estimate.
What changed in the portfolio
Dec 31, 2025 → Mar 31, 2026| Action | Holding | Weight before | Weight after | Shares vs flows |
|---|---|---|---|---|
| Exit | EXASExact Sciences Corp | 6.43% | — | — |
| Exit | HOLXHologic Inc | 4.07% | — | — |
| New position | QIAGEN NV | — | 3.56% | — |
| Exit | QIAGEN NV | 3.55% | — | — |
| New position | TEMTempus AI Inc. | — | 3.34% | — |
| Increase | VEEVVeeva Systems Inc | 6.08% | 8.53% | +38.5% |
| Exit | CORMasimo Corp | 2.23% | — | — |
| New position | WAYWaystar Holding Corp | — | 1.49% | — |
| New position | CAICaris Life Sciences Inc. | — | 1.30% | — |
| New position | HTFLHEARTFLOW INC | — | 1.23% | — |
0 new, 0 exited, 0 increased and 0 decreased between the fund's two latest holdings reports; turnover 12.0%. Full holdings and history
ETF Profile
holdings as of 2026-09-30
Holdings
39
AUM
$2.8M
Provider
Nport
Inception
2022-03-22
Exchange
XNAS
Data As Of
2026-09-30
Expense Ratio
0.65%
Dividend Yield
—
Distribution
—
Asset Allocation
Top Holdings
top 39 of 39 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | 8.78% | Equity (common) | US |
| IQV | IQVIA Holdings Inc | 8.66% | Equity (common) | US |
| DXCM | Dexcom Inc | 6.46% | Equity (common) | US |
| RMD | ResMed Inc | 6.43% | Equity (common) | US |
| EXAS | Exact Sciences Corp | 6.43% | Equity (common) | US |
| VEEV | Veeva Systems Inc | 6.08% | Equity (common) | US |
| GH | Guardant Health Inc | 5.19% | Equity (common) | US |
| ILMN | Illumina Inc | 4.81% | Equity (common) | US |
| NTRA | Natera Inc | 4.75% | Equity (common) | US |
| HOLX | Hologic Inc | 4.07% | Equity (common) | US |
| ALGN | Align Technology Inc | 4.03% | Equity (common) | US |
| GMED | Globus Medical Inc | 3.91% | Equity (common) | US |
| — | QIAGEN NV | 3.55% | Equity (common) | NL |
| PODD | Insulet Corp | 3.06% | Equity (common) | US |
| HIMS | Hims & Hers Health Inc | 2.50% | Equity (common) | US |
| COR | Masimo Corp | 2.23% | Equity (common) | US |
| DOCS | Doximity Inc | 2.17% | Equity (common) | US |
| IRTC | iRhythm Technologies Inc | 1.79% | Equity (common) | US |
| ATEC | Alphatec Holdings Inc | 1.31% | Equity (common) | US |
| TMDX | TransMedics Group Inc | 1.25% | Equity (common) | US |
| OSCR | Oscar Health Inc | 1.24% | Equity (common) | US |
| VCYT | Veracyte Inc | 1.04% | Equity (common) | US |
| ADPT | Adaptive Biotechnologies Corp | 1.02% | Equity (common) | US |
| — | Establishment Labs Holdings In | 0.93% | Equity (common) | CR |
| PRVA | Privia Health Group Inc | 0.89% | Equity (common) | US |
| INSP | Inspire Medical Systems Inc | 0.83% | Equity (common) | US |
| PGNY | Progyny Inc | 0.61% | Equity (common) | US |
| PRCT | PROCEPT BioRobotics Corp | 0.59% | Equity (common) | US |
| BBNX | Beta Bionics Inc | 0.59% | Equity (common) | US |
| TWST | Twist Bioscience Corp | 0.58% | Equity (common) | US |
| TXG | 10X Genomics Inc | 0.58% | Equity (common) | US |
| LFST | LifeStance Health Group Inc | 0.56% | Equity (common) | US |
| NEO | NeoGenomics Inc | 0.55% | Equity (common) | US |
| QDEL | QuidelOrtho Corp | 0.55% | Equity (common) | US |
| TNDM | Tandem Diabetes Care Inc | 0.54% | Equity (common) | US |
| TDOC | Teladoc Health Inc | 0.49% | Equity (common) | US |
| SDGR | Schrodinger Inc/United States | 0.37% | Equity (common) | US |
| HNGE | Hinge Health Inc | 0.32% | Equity (common) | US |
| — | MSILF Treasury Portfolio | 0.07% | Short-term investment | US |
Chart
Seasonality
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -- | 7.28% | 1.10% | 8.54% | 0.00% | 4.23% |
| Feb | -- | -4.44% | 0.37% | -5.37% | -4.97% | -3.60% |
| Mar | 5.47% | 3.32% | 4.05% | -8.48% | -9.17% | -0.96% |
| Apr | -21.63% | 1.94% | -4.06% | 1.47% | 0.40% | -4.38% |
| May | -10.20% | -2.91% | -1.87% | 8.02% | 4.16% | -0.56% |
| Jun | -2.90% | 5.44% | -0.22% | 4.53% | 7.16% | 2.80% |
| Jul | 10.39% | 1.74% | 2.89% | -3.11% | -0.01% | 2.38% |
| Aug | -7.07% | -10.12% | 5.74% | 2.16% | 10.26% | 0.19% |
| Sep | -7.48% | -14.09% | 2.61% | 0.96% | 8.97% | -1.81% |
| Oct | 9.87% | -12.09% | -1.92% | 5.39% | 0.76%* | 0.40% |
| Nov | 3.55% | 13.20% | 8.63% | 7.28% | -- | 8.16% |
| Dec | -6.27% | 10.64% | -6.67% | -2.94% | -- | -1.31% |
| Total | -27.05% | -4.39% | 10.10% | 18.11% | 17.09% | 2.77% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $23.13
SMA 50: $22.05
SMA 200: $18.89
Current: $23.42
EMA 12: $23.23
EMA 26: $22.83
MACD: 0.3981 | Signal: -0.1027
BULLISH
ADX (14): 21.97
WEAK TREND
+DI: 37.45
−DI: 27.99
Momentum Oscillators
RSI (14): 57.22
NEUTRAL
Stoch %K: 23.87
Stoch %D: 29.22
Williams %R: -56.06
Volume & Volatility
BB Upper: $24.23
BB Lower: $22.03
NEUTRAL
OBV: 226,089
Vol SMA 20: 12,326
Vol ROC: -83.60%
ATR: $0.44
True Range: $0.58
HV 20: 30.1%
HV 30: 27.2%
HV 60: 26.5%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-11T00:00:00 – 2026-10-09T00:00:00
AI Analysis
LLM Stock Analysis Report - EKG
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers: Strong momentum signals from technical indicators, supported by positive news sentiment. Primary risks include potential mean reversion and volatility contraction.
Primary Risks: Mean reversion and volatility contraction may lead to a pullback or consolidation.
2-3 Sentence Investment Thesis: EKG's recent price action is driven by strong momentum signals, with the stock trading above its short-term moving averages. While the technical picture looks favorable, the risk of mean reversion and volatility contraction cannot be ruled out. A cautious approach with a focus on risk management may be warranted.
Recent News Sentiment Impact: Positive news headline from GlobeNewswire Inc. (2024-11-11) has contributed to the stock's upward momentum.
Technical Analysis
Trend Direction:
- Short-term: Bullish
- Medium-term: Bullish
- Long-term: Neutral
Support/Resistance Levels: Upper Bollinger Band: $22.31, Middle: $20.40, Lower: $18.48
Momentum Signals:
- RSI interpretation: Overbought (76.50)
- MACD signal: Bullish
- Bollinger Bands position: Neutral
Volume Analysis: Volume is trending upward, with institutional interest signaled by the increasing volume flow.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headline from GlobeNewswire Inc. (2024-11-11) highlights EKG's innovative approach to safe weight loss.
Sentiment Assessment: Positive sentiment dominates, supporting the stock's upward momentum.
Catalyst Identification: Upcoming earnings release may provide additional catalyst for price movement.
Market Narrative: The positive news headline and strong technical signals are driving the market narrative, with investors focusing on EKG's growth potential.
Risk & Volatility Assessment
Beta Interpretation: Moderate volatility - stock generally follows market (beta: 0.93 vs SPY).
Volatility Regime: Historical volatility is moderate to high, with a current IV premium indicating a potentially richer than realized price environment.
Options Market Signals: Options market pricing a $2.02 move by expiration, with a put/call ratio of 0.00 (neutral sentiment).
Downside Protection: Support levels include the lower Bollinger Band ($18.48) and the short-term moving averages.
Market Context & Positioning
Sector Performance: EKG's sector is trading in line with the broader market.
Institutional Activity: Institutional interest is increasing, as signaled by the rising volume flow.
Correlation Analysis: EKG's price movement is relatively correlated to the broader market (R-squared: 0.5).
Relative Valuation: The stock is positioned within a trading range, with relative valuation indicating fair value.
Key Levels & Action Items
Critical Price Levels:
- Support: Lower Bollinger Band ($18.48), short-term moving averages
- Resistance: Upper Bollinger Band ($22.31)
Breakout/Breakdown Levels: A breakout above the upper Bollinger Band or a breakdown below the lower Bollinger Band could trigger significant price movements.
Time-Sensitive Catalysts: Upcoming earnings release may provide additional catalyst for price movement.
Risk Management:
- Stop-loss levels: Consider setting stop-loss orders near the short-term moving averages (SMA 20, SMA 50) or the lower Bollinger Band.
- Position sizing considerations: Adjust position size based on market conditions and risk tolerance.
Generated
News
All EKG news →
EKG Options Activity & IV Rank
EKG IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 63.5%
7-DTE IV: 176.8%
Expected Move: $2.40
7-DTE Move: $1.82
Days to Exp: 42 (2026-11-20)
Options Flow
Call Volume: 0
Put Volume: 0
P/C Volume: —
Call OI: 0
Put OI: 0
P/C OI: —
Total OI: 0
ATM Options Pricing
ATM Call: $1.30
ATM Put: $1.10
Call %: 5.6%
Put %: 4.7%
Chain Summary
Chain Volume: 0
Chain OI: 0
Last Updated: 10/9/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Oct 9 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Oct 9 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)96.5HighOct 9
IV Rank (30 DTE)61.2MediumOct 9
Straddle Price (30 DTE)$2.40Oct 9
Beta Analysis
Risk Metrics
Beta: 0.9046
Alpha: 15.80%
Correlation: 0.4802
R-Squared: 23.1%
Stock Volatility: 24.6%
Market Volatility: 13.0%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
EKG Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
2.65K
SI % of Float
1.33%
Days to Cover
1.00
Short Vol Ratio
18.4%
Free Float
—
Float %
—
Short interest 2026-09-30 • Short volume 2026-10-09
EKG Constituent Performance
Click any bar to view the full quote for that stock.
EKG Constituents (36 of 36)
| Symbol | Name | Weight % | Price | 1 Day | 1 Week | 1 Month |
|---|---|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | 8.78% | $423.96 | +2.06% | +8.17% | +14.85% |
| IQV | IQVIA Holdings Inc | 8.66% | $259.88 | +0.39% | +0.65% | -0.72% |
| DXCM | Dexcom Inc | 6.46% | $84.11 | -0.36% | -1.46% | +1.30% |
| RMD | ResMed Inc | 6.43% | $230.05 | +1.46% | +5.10% | +5.40% |
| EXAS | Exact Sciences Corp | 6.43% | $104.91 | +0.95% | +1.29% | +1.43% |
| VEEV | Veeva Systems Inc | 6.08% | $296.13 | +3.96% | +8.34% | +12.85% |
| GH | Guardant Health Inc | 5.19% | $167.47 | +1.15% | -5.81% | +6.41% |
| ILMN | Illumina Inc | 4.81% | $278.17 | +5.14% | +1.88% | +34.74% |
| NTRA | Natera Inc | 4.75% | $400.71 | +2.54% | -2.35% | +21.82% |
| HOLX | Hologic Inc | 4.07% | $76.01 | +0.48% | +0.45% | +0.36% |
| ALGN | Align Technology Inc | 4.03% | $142.71 | +1.19% | -0.72% | -5.38% |
| GMED | Globus Medical Inc | 3.91% | $74.65 | +1.80% | -1.26% | +0.62% |
| PODD | Insulet Corp | 3.06% | $135.28 | +0.60% | +2.73% | +2.52% |
| HIMS | Hims & Hers Health Inc | 2.50% | $30.92 | +10.19% | +6.62% | +12.40% |
| COR | Masimo Corp | 2.23% | $323.85 | +0.78% | +4.79% | +0.71% |
| DOCS | Doximity Inc | 2.17% | $30.5 | +3.81% | +9.20% | +19.23% |
| IRTC | iRhythm Technologies Inc | 1.79% | $106.7 | +4.00% | -3.33% | -4.24% |
| ATEC | Alphatec Holdings Inc | 1.31% | $10.67 | +3.09% | +6.38% | +0.85% |
| TMDX | TransMedics Group Inc | 1.25% | $77.87 | -1.43% | -2.41% | -5.24% |
| OSCR | Oscar Health Inc | 1.24% | $33.37 | +0.82% | +7.85% | +1.83% |
| VCYT | Veracyte Inc | 1.04% | $45.23 | +3.74% | -1.27% | +10.67% |
| ADPT | Adaptive Biotechnologies Corp | 1.02% | $26.49 | +1.53% | -6.56% | +9.46% |
| PRVA | Privia Health Group Inc | 0.89% | $20.85 | +3.27% | +2.71% | +2.11% |
| INSP | Inspire Medical Systems Inc | 0.83% | $68.89 | +3.30% | -1.54% | -5.63% |
| PGNY | Progyny Inc | 0.61% | $27.93 | +0.36% | +10.70% | +2.12% |
| PRCT | PROCEPT BioRobotics Corp | 0.59% | $18.4 | +2.79% | +7.23% | -9.72% |
| BBNX | Beta Bionics Inc | 0.59% | $17.63 | +1.15% | -7.01% | +6.40% |
| TWST | Twist Bioscience Corp | 0.58% | $159.78 | +5.08% | -15.31% | +25.59% |
| TXG | 10X Genomics Inc | 0.58% | $80.65 | +4.36% | -13.74% | +17.58% |
| LFST | LifeStance Health Group Inc | 0.56% | $12.42 | +2.99% | +4.99% | -4.24% |
| NEO | NeoGenomics Inc | 0.55% | $16.35 | +2.06% | -11.48% | -5.60% |
| QDEL | QuidelOrtho Corp | 0.55% | $13.42 | +8.14% | +24.61% | +13.92% |
| TNDM | Tandem Diabetes Care Inc | 0.54% | $16.11 | +2.78% | -2.36% | -5.84% |
| TDOC | Teladoc Health Inc | 0.49% | $5.77 | +4.15% | +4.53% | -6.33% |
| SDGR | Schrodinger Inc/United States | 0.37% | $27.28 | +3.37% | -10.00% | +43.43% |
| HNGE | Hinge Health Inc | 0.32% | $102.9 | +5.00% | +5.35% | +16.15% |